Ledger.Open graph →

SEC Form D · filed October 7, 2021

GeneCentric Therapeutics, Inc

Offering

$7.5M

Sold

$4.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DURHAM, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Michael V. Milburn · Durham, NCExec · Director Arnold V. Levine · Durham, NCDirector Ellen V. Lubman · Durham, NCDirector Myla V. Lai-Goldman · Durham, NCExec · Director Clay V. Thorp · Durham, NCDirector Deborah Wittman · Aurora, CODirector Brad Buscher · Aurora, CODirector Michael Montag · Aurora, COExec · Director David Bostwick · Aurora, COExec · Director John Harper · Aurora, CODirector Perou V. Charles · Durham, NCExec · Director Andrew Dodge · New York, NYDirector Errik Anderson · Boston, MADirector Donald A. Holzworth · Greenwood Village, COExec · Director Pamela J. Pure · Greenwood Village, COExec · Director Dylan L. Pure · Greenwood Village, CODirector Perou V. Charles · Durham, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗